This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.

Letters To the Editor

Reexamining Paroxetine and Cognitive-Behavioral Therapy in Postpartum Depression and Anxiety

Jennifer McClendon, MSW

Published: November 15, 2005

Article Abstract

Because this piece has no abstract, we have provided for your benefit the first 3 sentences of the full text.

Sir: The recent (September 2004) study by Misri et al.1evaluating the use of paroxetine and cognitive-behavioraltherapy (CBT) to treat postpartum depression and anxiety istimely and informative; however, I have several concerns.The results of the study are not generalizable to the majorityof women with postpartum depression and anxiety. At best, thesample is representative only of the very small subset of womenwith severe comorbid anxiety and depression who are diagnosedby their primary care physician and referred for specialtycare.’ ‹

Some JCP and PCC articles are available in PDF format only. Please click the PDF link at the top of this page to access the full text.

Related Articles

Volume: 66

Quick Links: Depression (MDD)

Sign-up to stay
up-to-date today!


Already registered? Sign In

Case Report

Safety and Tolerability of Concomitant Intranasal Esketamine Treatment With Irreversible, Nonselective MAOIs: A Case Series

Three cases suggest that concomitant use of intranasal esketamine with an irreversible, nonselective MAOI is safe in...